A FIRST-IN-HUMAN PHASE 1/2A CLINICAL STUDY OF ICM-203 AAV GENE THERAPY: PROMISING SIGNALS AS A DMOAD CANDIDATE

Heald, A; Solomon, L Bogdan; Page, Richard; Yum, YN; Park, M; Myung, J; Collins, JE; Guermazi, A; Kim, DW

A FIRST-IN-HUMAN PHASE 1/2A CLINICAL STUDY OF ICM-203 AAV GENE THERAPY: PROMISING SIGNALS AS A DMOAD CANDIDATE

journal contribution

posted on 2025-07-23, 05:33 authored by A Heald, L Bogdan Solomon, Richard PageRichard Page, YN Yum, M Park, J Myung, JE Collins, A Guermazi, DW Kim

A FIRST-IN-HUMAN PHASE 1/2A CLINICAL STUDY OF ICM-203 AAV GENE THERAPY: PROMISING SIGNALS AS A DMOAD CANDIDATE<p></p>

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.ostima.2025.100291

Location

Amsterdam, The Netherlands

Open access

Yes

Language

eng

Publication classification

E3 Extract of paper

Journal

Osteoarthritis Imaging

Volume

5

Article number

100291

Pagination

21-21

ISSN

2772-6541

eISSN

2772-6541

Issue

Supplement 1

Publisher

Elsevier

Usage metrics

Keywords

Aging Arthritis Chronic Pain Clinical Research Clinical Trials and Supportive Activities Health Disparities Osteoarthritis Pain Research Musculoskeletal 6.1 Pharmaceuticals

Licence

CC BY-NC-ND 4.0

A FIRST-IN-HUMAN PHASE 1/2A CLINICAL STUDY OF ICM-203 AAV GENE THERAPY: PROMISING SIGNALS AS A DMOAD CANDIDATE

History

Related Materials

Location

Open access

Language

Publication classification

Journal

Volume

Article number

Pagination

ISSN

eISSN

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports